Last reviewed · How we verify
NCT04373980
Conventional Versus LED Phototherapy and Their Effect on Lymphocytes Subsets of Full Term Neonates With Hyperbilirubinemia
NA trial testing phototherapy in Neonatal Hyperbilirubinemia in 60 participants. Completed in 1 January 2020.
30 July 2019
Quick facts
| Lead sponsor | Rania Ali El-Farrash |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 January 2019 |
| Primary completion | 30 July 2019 |
| Estimated completion | 1 January 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- phototherapy
Conditions studied
- Neonatal Hyperbilirubinemia — all drugs for Neonatal Hyperbilirubinemia →
- Phototherapy Complication — all drugs for Phototherapy Complication →
Sponsor
Rania Ali El-Farrash — full company profile →
Who can join
Adults 1 Day to 28 Days, any sex, with Neonatal Hyperbilirubinemia or Phototherapy Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the influence of the use of different types of phototherapy on different lymphocytes subsets CD4 and CD8 in the treatment of hyperbilirubinemia in neonates.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04373980
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of phototherapy
Trials testing the same drug.
- NCT04218318 — Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn · NA · recruiting
- NCT03718962 — The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo Patients · NA · completed
- NCT03005730 — Photobiomodulation In the Masseter and Temporal In Patients With Temporomandibular Joint Dysfunction · NA · completed
- NCT03416998 — Photobiomodulation On Muscle Recovery In Professional Soccer Players · NA · completed
Other recruiting trials for Neonatal Hyperbilirubinemia
Currently open trials in the same condition.
- NCT07346976 — Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-D · NA · recruiting
- NCT06832800 — Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH · EARLY_PHASE1 · recruiting
- NCT06702241 — Newborn Jaundice - An Investigation of Different Approaches to Light Therapy · Phase 2, PHASE3 · recruiting
- NCT06687746 — Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns · active not recruiting
- NCT06517862 — Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia · Phase 4 · recruiting
Other Rania Ali El-Farrash trials
Trials by the same sponsor.
- NCT03767361 — Study the Effect of Blood Transfusion on Oxidant-antioxidant Status in Term and Near-term Neonates · EARLY_PHASE1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04373980 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rania Ali El-Farrash
- Last refreshed: 5 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04373980.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing